TY  - GEN
AU  - Montalescot,Gilles
AU  - Zeymer,Uwe
AU  - Silvain,Johanne
AU  - Boulanger,Bertrand
AU  - Cohen,Marc
AU  - Goldstein,Patrick
AU  - Ecollan,Patrick
AU  - Combes,Xavier
AU  - Huber,Kurt
AU  - Pollack,Charles
AU  - Bénezet,Jean-François
AU  - Stibbe,Olivier
AU  - Filippi,Emmanuelle
AU  - Teiger,Emmanuel
AU  - Cayla,Guillaume
AU  - Elhadad,Simon
AU  - Adnet,Frédéric
AU  - Chouihed,Tahar
AU  - Gallula,Sébastien
AU  - Greffet,Agnès
AU  - Aout,Mounir
AU  - Collet,Jean-Philippe
AU  - Vicaut,Eric
TI  - Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial
SN  - 1474-547X
PY  - 2011///0913
KW  - Aged
KW  - Angioplasty, Balloon, Coronary
KW  - Anticoagulants
KW  - administration & dosage
KW  - Electrocardiography
KW  - Enoxaparin
KW  - Female
KW  - Fibrinolytic Agents
KW  - Heparin
KW  - Humans
KW  - Injections, Intravenous
KW  - Male
KW  - Middle Aged
KW  - Myocardial Infarction
KW  - mortality
KW  - Platelet Aggregation Inhibitors
KW  - therapeutic use
KW  - Recurrence
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S0140-6736(11)60876-3
ER  -